Physician profile
Keith Chumley
NPI 1932126653
$1,177.47
in general payments reported to CMS, 2019-2025
17 companies · $687 in 2025
The $687 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $49.70 · 2021: $18.01 · 2022: $21.20 · 2023: $52.39 · 2024: $23.10 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Education: $6.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.98 |
| Education | $6.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $201.17 | 2023-2025 | Mounjaro, Jardiance |
| Amgen INC. | $192.48 | 2019-2025 | Repatha, Otezla |
| Novo Nordisk INC | $125.00 | 2025 | Ozempic |
| Glaxosmithkline, LLC. | $123.00 | 2019-2020 | |
| Gilead Sciences, INC. | $120.36 | 2025 | Vemlidy |
| Pfizer INC. | $105.00 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $90.53 | 2019-2025 | Farxiga |
| Exact Sciences Corporation | $55.38 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Harmony Biosciences LLC | $23.10 | 2024 | |
| Sumitomo Pharma America, INC. | $22.28 | 2025 | Gemtesa |
| Amarin Pharma, INC. | $21.83 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.67 | 2019 | |
| Abbvie INC. | $18.01 | 2021 | |
| Lucid Diagnostics INC. | $17.37 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $16.30 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.80 | 2019 | |
| Sanofi Pasteur INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Chumley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.